3 Reasons Retirees Should Reconsider Enrolling in a Standalone Medicare Drug Plan in 2026

Photo of Ian Cooper
By Ian Cooper Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
3 Reasons Retirees Should Reconsider Enrolling in a Standalone Medicare Drug Plan in 2026

© Inna Kot / Shutterstock.com

You turn 65, sign up for Medicare, and a wall of mail arrives pushing standalone Part D drug plans. The default move for decades has been to pick one and forget it. For 2026, that default deserves a fresh look. The Inflation Reduction Act fully kicks in this year, premiums and surcharges shift, and bundled Medicare Advantage plans now compete aggressively for the same enrollees.

Part D still matters. The late enrollment penalty is permanent and often misunderstood. The real question is which drug coverage path fits your situation, especially if you take a few medications today.

The 2026 numbers that frame the decision

  1. Part D national base beneficiary premium of $38.99 per month: This is the benchmark figure CMS uses to calculate late enrollment penalties and IRMAA surcharges. The figure rose 6% from $36.78 in 2025, the maximum annual increase permitted under the Inflation Reduction Act’s premium stabilization provision. Actual plan premiums vary by carrier and state, but this base drives the math behind every surcharge calculation.
  2. Maximum Part D deductible of $615: Plans can charge less, but no standalone drug plan can require you to pay more than this before cost-sharing begins. Many low-premium plans hit this cap, so factor it into total-cost comparisons rather than focusing solely on the monthly premium.
  3. Annual out-of-pocket cap on prescriptions of $2,100: The headline change from the Inflation Reduction Act introduced a $2,000 cap in 2025 and indexed it upward. For 2026, CMS set the threshold at $2,100. Once your true out-of-pocket drug spending reaches that level, you pay nothing more for covered medications for the rest of the year, eliminating the old catastrophic coinsurance phase. Ten high-cost drugs, including Eliquis, Jardiance, and Xarelto, also carry federally negotiated Maximum Fair Prices for the first time in 2026, further reducing what many enrollees owe before hitting the cap.
  4. IRMAA surcharge range for higher-income retirees of $14.50 to $91.00 per month: Retirees with modified adjusted gross income above $109,000 (single filers) or $218,000 (joint filers) pay this surcharge on top of their plan premium. Because IRMAA is added regardless of which Part D plan you choose, high earners benefit most from selecting the lowest-premium compliant plan. Note that the surcharge is based on your 2024 tax return, so income decisions made two years ago are already baked into your 2026 bill.

For a retiree paying around $42 a month in premiums for 25 years, the total outlay reaches roughly $12,600, which can exceed what they ever recoup at the pharmacy counter.

Why did the math change this year?

The single biggest shift is the $2,100 annual out-of-pocket cap and the elimination of the catastrophic coinsurance phase. Before this rule, a cancer drug or specialty medication could expose a retiree to five-figure annual costs. Now the worst-case pharmacy bill is capped. Premiums fund routine cost-sharing on prescriptions you actually fill, with catastrophic risk already contained by statute.

For a retiree on no medications, the expected value of a richer plan drops sharply. For someone on three or four maintenance drugs, the cap remains useful, but the premium gap between the cheapest plan and a mid-tier plan rarely pays off. Adding to the picture: Medicare’s drug price negotiation program brought 10 widely used medications to negotiated prices on January 1, 2026, cutting cost-sharing for those drugs by roughly 50% on average, according to an AARP Public Policy Institute analysis.

The trap on the other side is the late enrollment penalty. Skip Part D for five years and the Social Security Administration adds about $23 a month to your premium for life, based on 1% of the $38.99 base premium multiplied by 60 uncovered months. That comes to roughly $280 a year, every year, forever. The penalty math alone is why a placeholder plan beats no plan.

Three reasons to reconsider a standalone plan

  1. The cheapest compliant plan often wins. If you take few or no drugs, Part D’s role in 2026 is mainly to avoid the lifetime penalty and give you access to the $2,100 cap if your health changes. Paying for a richer formulary you don’t use drags on total cost. The lowest-premium plan in your state, paired with GoodRx (NASDAQ: GDRX | GDRX Price Prediction) or Costco (NASDAQ: COST) cash pricing for cheap generics, frequently beats a mid-tier plan on total annual spend.
  2. A Medicare Advantage drug plan (MA-PD) may already include it. If you are weighing Original Medicare plus Medigap plus standalone Part D against an MA-PD bundle, the bundle combines drug coverage into a single premium. The tradeoff is network restrictions and prior authorization requirements. For healthy retirees who value a single bill and lower upfront cost, MA-PD removes the standalone Part D decision entirely. For those who travel often or want any-provider access, Original Medicare plus standalone Part D still has the edge.
  3. IRMAA surcharges punish high earners twice. A retiree in the top income band pays the Part B surcharge plus a Part D IRMAA of up to $91 a month. Add the $38.99 base premium and you’re already at roughly $130 a month, pushing annual Part D cost toward $1,560 before a single prescription is filled. If your modified AGI puts you in IRMAA territory, the cheapest base plan limits the surcharge damage, since the IRMAA amount is added on top regardless of which plan you choose.

What to do during open enrollment

Evaluate your actual medication list and your projected income two years out, since IRMAA looks back at your 2024 tax return for 2026 premiums. If you have creditable drug coverage through a former employer or a spouse’s active plan, document it carefully. That coverage defers the penalty clock, and losing it later triggers a special enrollment window without lifetime surcharges.

The common, costly mistake is autopilot. Plans change formularies and premiums every year. Re-shop annually on Medicare.gov’s plan finder using your current drug list. Five minutes of effort routinely saves several hundred dollars, and it is the only way to ensure the cap, the premium, and your prescriptions still line up.

Editor’s note: This article has been updated to reflect CMS-confirmed 2026 figures, including the Part D base beneficiary premium of $38.99 (up from $36.78 in 2025), the maximum deductible of $615, the $2,100 annual out-of-pocket cap (indexed up from $2,000 in 2025), a revised late enrollment penalty calculation based on the new base premium, and the first-year effect of federally negotiated drug prices on 10 widely used medications.

Contact [email protected] for any questions or corrections.

Photo of Ian Cooper
About the Author Ian Cooper →

Ian Cooper is a veteran market analyst and investment strategist with more than 20 years of experience covering stocks, commodities, and macro trends. Since 1999, he has helped investors identify market opportunities using a blend of technical analysis, fundamental research, and market sentiment.

He is the creator of the ADD News Flow Strategy, which focuses on trading market reactions to major news events and investor psychology. Cooper was also among the analysts who warned about the 2008 financial crisis and major financial institution collapses ahead of the broader market.

Before joining 247 Wall St., Cooper wrote extensively for InvestorPlace and other financial publications, covering market trends, trading strategies, and investment opportunities.

Continue Reading

Top Gaining Stocks

TRV Vol: 4,279,412
STX Vol: 6,997,046
CNC Vol: 4,773,249
HUM Vol: 2,000,148
ADM Vol: 4,154,356

Top Losing Stocks

ISRG Vol: 11,521,143
CDNS Vol: 5,182,285
CTRA Vol: 73,319,495
SNPS Vol: 5,022,218
NFLX Vol: 141,179,846